Home/Theratome Bio/Michael Coleman

MC

Michael Coleman

Chief Scientific Officer

Therapeutic Areas

Ophthalmology Transplant Medicine Regenerative Medicine

Theratome Bio Pipeline

Drug	Indication	Phase
Organ Preservation Product	Organ Transplant Preservation (e.g., Heart)	Pre-clinical
KM102	Dry Eye Disease	Pre-clinical

Leadership Team at Theratome Bio

Michael T. Redman

Chief Executive Officer

Keith L. March, MD, PhD, FACC

Scientific Founder, Board Member

Chief Financial Officer

View full Theratome Bio profile